From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA conditionally approves Tanovea-CA1, the first new animal drug for treating lymphoma in dogs

from FDA

The U.S. Food and Drug Administration today announced the conditional approval of Tanovea-CA1 (rabacfosadine for injection), the first new animal drug intended to treat canine lymphoma. Also called lymphosarcoma, lymphoma is a type of cancer in dogs. The active ingredient in Tanovea-CA1 is rabacfosadine, a substance that kills rapidly growing cancer cells. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063